Anabolic-Androgenic Steroids (2025-2026 Recording)
Availability
On-Demand
Access expires on Jun 30, 2027
Cost
Member: $0.00
Non-Member: $39.00

This session provides a focused overview of anabolic-androgenic steroid (AAS) use in addiction medicine, including key concepts in epidemiology, patterns of misuse, and associated health risks, aligned with the ACAAM National Addiction Medicine Didactic Curriculum and ABPM content areas.

What This Covers
• Definitions, epidemiology, and patterns of anabolic-androgenic steroid misuse, including cycling and stacking practices
• Clinical recognition of AAS use disorder, including DSM-5 considerations
• Withdrawal syndromes and psychiatric and behavioral effects associated with AAS use
• Medical complications, with emphasis on cardiovascular, endocrine, and hepatic risks
• Assessment strategies and laboratory evaluation in patients using AAS
• Management of withdrawal and co-occurring conditions
• Harm reduction approaches and evidence-informed strategies for clinical care
• Case-based application of approaches to diagnose and manage AAS use and related complications

How This Resource Is Used
This session is designed for on-demand learning and targeted content review. It can be used to reinforce specific knowledge areas or as part of structured board preparation.

Karen Antwiler, MD

Karen D. Antwiler, MD FASAM

Dr. Antwiler is an addiction medicine physician at Eisenhower Health and serves as Associate Program Director for the Addiction Medicine Fellowship. She is board certified in Family Medicine and Addiction Medicine.

She received her medical degree from SRM Medical College and completed her residency and fellowship training at Eisenhower Medical Center, where her work focuses on the treatment of substance use disorders.

Sanoara Mazid, MD

Dr. Mazid is a family medicine physician who, at the time of this presentation (March 2026), was an Addiction Medicine Fellow at Eisenhower Health.

 

A professional headshot of a person in a white lab coat, with a logo on the coat, set against a blurred background.

Julia Oberndorf, MD

Dr. Oberndorf is an internal medicine physician who, at the time of this presentation (March 2026), was an Addiction Medicine Fellow at Eisenhower Health.

 

To support a meaningful learning experience and recognize your participation:

  • The evaluation will become available after you have viewed the video in its entirety
  • We encourage you to complete the evaluation to reflect on the content and provide valuable feedback

Access Period
Access to this recording is available through June 30, 2027, in alignment with ACAAM’s annual academic cycle.

Recording Release Cycle
ACAAM releases updated recorded sessions each July based on the prior academic year’s didactic series. These recordings are available for a limited time and are retired on June 30 of the following year as new content is released.

Powered By